Lei Shi

Molecular Biology · with Chen · 2023

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Lei Shi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain

Papers from Lei Shi's perspective

Ordered by how strongly the researchers Lei Shi trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (Cancer Cell)
  3. Molecular mechanisms and clinical applications of angiogenesis (Nature)
  4. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
  5. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
  6. Basic and therapeutic aspects of angiogenesis. (Cell)
  7. Opinion: Angiogenesis: an organizing principle for drug discovery? (Nature reviews. Drug discovery)
  8. New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
  9. Sorafenib in advanced clear-cell renal-cell carcinoma. (New England Journal of Medicine)
  10. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (Cancer Research)

Their papers